MedNews

  • Drug Industry News
  • FDA News & Alerts
  • Health & Medical News
You are here: Home / Archives for MedNews

New Type of Milk May Help Lower Cholesterol

July 8, 2007 By MedNews Leave a Comment

At a time when one out of every two American adults has borderline or high cholesterol, Kroger is advertising a new milk that can reduce your LDL.

Filed Under: General Health Tagged With: cholesterol, food

Doctors: TB traveler’s diagnosis more treatable than thought

July 6, 2007 By MedNews Leave a Comment

Dr. Charles Daley, with the National Jewish Medical and Research Center, told reporters that multiple tests indicate Andrew Speaker suffers from multidrug-resistant tuberculosis, which is still serious and resistant to most of the common drugs used to treat tuberculosis.

Filed Under: Infectious Diseases Tagged With: TB, tuberculosis

Prescribing Information Change: Rocephin (ceftriaxone sodium) for Injection

July 6, 2007 By MedNews Leave a Comment

Prescribing Information revised to provide new information regarding the potential risk associated with concomitant use of Rocephin with calcium or calcium containing solutions or products.

Filed Under: FDA News & Alerts Tagged With: calcium, ceftriaxone sodium, Rocephin

Organic food ‘better’ for heart

July 5, 2007 By MedNews Leave a Comment

Organic fruit and vegetables may be better for you than conventionally grown crops, US research suggests.

Filed Under: Uncategorized Tagged With: heart, organic food

Yawning may keep us ‘on the ball’

July 4, 2007 By MedNews Leave a Comment

It may appear the height of rudeness, but a study suggests yawning is the body’s way of keeping you awake.

Filed Under: Sleep Tagged With: sleep

Poor Sense Of Smell May Be Sign Of Alzheimer’s Disease

July 3, 2007 By MedNews Leave a Comment

Difficulty identifying common smells such as lemon, banana and cinnamon may be the first sign of Alzheimer’s disease, according to a study that could lead to scratch-and-sniff tests to determine a person’s risk for the progressive brain disorder.

Filed Under: Alzheimer's Tagged With: alzheimers

AstraZeneca Diabetes Drug Dapagliflozin Shows Promise

June 28, 2007 By MedNews Leave a Comment

A new, experimental diabetes drug from AstraZeneca and Bristol-Myers Squibb called dapagliflozin, a Type 2 diabetes treatment developed showed some positive results, according to a presentation at the American Diabetes Association annual conference.

The companies reported that "no discontinuations due to adverse events and no serious adverse events" occurred. Furthermore, pre-clinical data also revealed that in tests on diabetic rats, the treatment significantly reduced plasma glucose levels–in some cases only two hours after a first dose.

Filed Under: Diabetes Tagged With: AstraZeneca, Bristol-Myers Squibb, dapagliflozin, Diabetes

Doctor Says New Hormonal Therapy for Menopause Considered “Unsafe”

June 21, 2007 By MedNews Leave a Comment

Bio-identical hormones have been a new alternative to the United States for women in menopause.
Although this form of hormonal treatment may be hope to many women, doctors say that it’s misleading. Bio-identical hormones may pose greater health risks than conventional therapy.

Filed Under: Menopause Tagged With: hormone therapy, hrt, menopause

Addicted to the Internet? You may have ADHD

June 21, 2007 By MedNews Leave a Comment

A study performed at Kaohsiung Medical University in Taiwan set out to investigate the links between emotional conditions such as anxiety, depression and ADHD and Internet addiction. Two thousand fourteen students, 1204 male and 910 female, were assessed for all of the above factors using a self-report questionnaire.

Filed Under: ADD/ADHD, Addiction Tagged With: ADD, addiction, ADHD, internet addiction

Lawsuit Charges Glaxo Failed to Warn of Diabetes Drug Risk

June 21, 2007 By MedNews Leave a Comment

The widow and son of a Texas man who was taking a GlaxoSmithKline Plc diabetes drug at the time of his fatal heart attack has sued the drugmaker, claiming that it failed to warn of the drug’s heart risks, according to court papers.

The claim involves rosiglitazone, which is sold under the brand names Avandia and Advandamet. Investors have been bracing for a flood of litigation against Glaxo after a widely publicized medical report last month suggested that Avandia increases the risk of heart attack and death.

Filed Under: Diabetes Tagged With: advandamet, avandia, Diabetes, glaxo, rosiglitazone

« Previous Page
Next Page »

Search



Tag Cloud

alcohol allergies alzheimers antibiotics breast cancer cancer Centers for Disease Control (CDC) children cholesterol dementia depression Diabetes diet drug abuse exercise fda flu food genetics geriatrics h1n1 heart heart attack heart disease high blood pressure HIV/AIDS hormone therapy hypertension lungs menopause NIH obesity pain pediatrics pregnancy prostate cancer seniors sleep smoking statistics stroke sun teens USA women's health

Recent Comments

  • Mia Fritz on Health Benefits of Dark Chocolate
  • Shilpa on Why Too Much Iron Can Be Dangerous
  • Racheal on Teen Pregnancy May Be Reduced by Sex Education in Schools, Says Study
  • Don on Prilosec, Nexium and Prevacid Tied to Higher Risk of Pneumonia
  • Meso on Brain Changes in Elderly Can Affect Mobility and Balance
  • About Us
  • Contact

Copyright © 2025 Mednews · Log in